KUALA LUMPUR, Aug 7 ― The public is advised against going for Covid-19 antibody test as there is still no clinical guidelines issued on the matter, said Coordinating Minister for the National Covid-19 Immunisation Programme (PICK) Khairy Jamaluddin. He said based on guidelines issued by the.
Though regulators warn against using antibody tests as a predictor of a vaccine’s effectiveness, companies have been marketing to patients and medical professionals alike the idea that antibody tests
The kit will be useful for understanding the Covid-19 epidemiology and assessing an individual s previous SARSaCoVa2 exposure.
There will soon be a new and more efficient COVID-19 antibody test in the Indian market. The Defence Research and Development Organisation (DRDO) has developed an antibody detection kit known as Dipcovan, which is expected to be available at Rs 75 per test in the market from June first week onwards. According to DRDO, one of its labs, the Defence Institute of Physiology and Allied Sciences (DIPAS) along with Vanguard Diagnostics Pvt Ltd has developed this antibody detection-based kit.
97 per cent sensitivity and 99 per cent specificity